INGLES MARKETS INC-CLASS A (IMKTA)

US4570301048 - Common Stock

72.17  -0.13 (-0.18%)

After market: 72.17 0 (0%)

Fundamental Rating

6

IMKTA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 40 industry peers in the Consumer Staples Distribution & Retail industry. Both the health and profitability get an excellent rating, making IMKTA a very profitable company, without any liquidiy or solvency issues. IMKTA has a valuation in line with the averages, but on the other hand it scores bad on growth.



8

1. Profitability

1.1 Basic Checks

In the past year IMKTA was profitable.
IMKTA had a positive operating cash flow in the past year.
In the past 5 years IMKTA has always been profitable.
Each year in the past 5 years IMKTA had a positive operating cash flow.

1.2 Ratios

The Return On Assets of IMKTA (7.52%) is better than 85.00% of its industry peers.
Looking at the Return On Equity, with a value of 12.36%, IMKTA is in the better half of the industry, outperforming 67.50% of the companies in the same industry.
The Return On Invested Capital of IMKTA (8.81%) is better than 70.00% of its industry peers.
IMKTA had an Average Return On Invested Capital over the past 3 years of 13.23%. This is above the industry average of 10.26%.
The last Return On Invested Capital (8.81%) for IMKTA is well below the 3 year average (13.23%), which needs to be investigated, but indicates that IMKTA had better years and this may not be a problem.
Industry RankSector Rank
ROA 7.52%
ROE 12.36%
ROIC 8.81%
ROA(3y)10.93%
ROA(5y)9.31%
ROE(3y)20.5%
ROE(5y)19.12%
ROIC(3y)13.23%
ROIC(5y)11.98%

1.3 Margins

IMKTA's Profit Margin of 3.14% is amongst the best of the industry. IMKTA outperforms 87.50% of its industry peers.
In the last couple of years the Profit Margin of IMKTA has grown nicely.
Looking at the Operating Margin, with a value of 4.31%, IMKTA belongs to the top of the industry, outperforming 82.50% of the companies in the same industry.
In the last couple of years the Operating Margin of IMKTA has grown nicely.
IMKTA's Gross Margin of 23.51% is in line compared to the rest of the industry. IMKTA outperforms 55.00% of its industry peers.
In the last couple of years the Gross Margin of IMKTA has remained more or less at the same level.
Industry RankSector Rank
OM 4.31%
PM (TTM) 3.14%
GM 23.51%
OM growth 3Y-6.43%
OM growth 5Y10.14%
PM growth 3Y-2.62%
PM growth 5Y8.49%
GM growth 3Y-2.84%
GM growth 5Y-0.09%

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IMKTA is creating value.
Compared to 1 year ago, IMKTA has about the same amount of shares outstanding.
IMKTA has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, IMKTA has an improved debt to assets ratio.

2.2 Solvency

IMKTA has an Altman-Z score of 4.74. This indicates that IMKTA is financially healthy and has little risk of bankruptcy at the moment.
IMKTA has a Altman-Z score of 4.74. This is in the better half of the industry: IMKTA outperforms 70.00% of its industry peers.
The Debt to FCF ratio of IMKTA is 11.67, which is on the high side as it means it would take IMKTA, 11.67 years of fcf income to pay off all of its debts.
IMKTA has a Debt to FCF ratio (11.67) which is comparable to the rest of the industry.
IMKTA has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of IMKTA (0.36) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 11.67
Altman-Z 4.74
ROIC/WACC1.2
WACC7.31%

2.3 Liquidity

IMKTA has a Current Ratio of 3.22. This indicates that IMKTA is financially healthy and has no problem in meeting its short term obligations.
IMKTA has a Current ratio of 3.22. This is amongst the best in the industry. IMKTA outperforms 90.00% of its industry peers.
IMKTA has a Quick Ratio of 1.45. This is a normal value and indicates that IMKTA is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.45, IMKTA belongs to the best of the industry, outperforming 82.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 1.45

2

3. Growth

3.1 Past

IMKTA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.02%.
The Earnings Per Share has been growing by 18.30% on average over the past years. This is quite good.
IMKTA shows a small growth in Revenue. In the last year, the Revenue has grown by 1.73%.
IMKTA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.56% yearly.
EPS 1Y (TTM)-33.02%
EPS 3Y8.08%
EPS 5Y18.3%
EPS growth Q2Q-37.53%
Revenue 1Y (TTM)1.73%
Revenue growth 3Y8.52%
Revenue growth 5Y7.56%
Revenue growth Q2Q-0.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

5

4. Valuation

4.1 Price/Earnings Ratio

IMKTA is valuated cheaply with a Price/Earnings ratio of 7.42.
Based on the Price/Earnings ratio, IMKTA is valued cheaply inside the industry as 95.00% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 28.02. IMKTA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.42
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IMKTA indicates a rather cheap valuation: IMKTA is cheaper than 92.50% of the companies listed in the same industry.
62.50% of the companies in the same industry are more expensive than IMKTA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 29.06
EV/EBITDA 4.46

4.3 Compensation for Growth

IMKTA has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.41
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a yearly dividend of 0.91%, IMKTA is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.53, IMKTA pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.91, IMKTA pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 0.91%

5.2 History

The dividend of IMKTA has a limited annual growth rate of 0.16%.
IMKTA has been paying a dividend for at least 10 years, so it has a reliable track record.
IMKTA has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.16%
Div Incr Years0
Div Non Decr Years10

5.3 Sustainability

IMKTA pays out 6.62% of its income as dividend. This is a sustainable payout ratio.
IMKTA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP6.62%
EPS Next 2YN/A
EPS Next 3YN/A

INGLES MARKETS INC-CLASS A

NASDAQ:IMKTA (5/6/2024, 7:07:26 PM)

After market: 72.17 0 (0%)

72.17

-0.13 (-0.18%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.37B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.91%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 7.42
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.41
Profitability
Industry RankSector Rank
ROA 7.52%
ROE 12.36%
ROCE
ROIC
ROICexc
ROICexgc
OM 4.31%
PM (TTM) 3.14%
GM 23.51%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.39
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.22
Quick Ratio 1.45
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-33.02%
EPS 3Y8.08%
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)1.73%
Revenue growth 3Y8.52%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y